-
Mashup Score: 2
I recently had the pleasure of attending a symposium at the Cleveland Clinic that featured an outstanding review of immune-related adverse events, and I was reminded of how far we have come in the decade since I first became involved in the evolution of this disease class.For rheumatologists, this topic — which is covered elsewhere in this issue of Healio Rheumatology by Alexa Meara, MD, a
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 5Dr. Tedros, WHO Director-General, presents Oxfam resolution at Moderna's annual shareholder meeting - 1 year(s) ago
Dr. Tedros, WHO Director-General, presents Oxfam resolution at Moderna’s annual shareholder meeting to urge them to share vaccine technology with the world.G…
Source: YouTubeCategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 4Dr. Tedros, WHO Director-General, presents Oxfam resolution at Moderna's annual shareholder meeting - 1 year(s) ago
Dr. Tedros, WHO Director-General, presents Oxfam resolution at Moderna’s annual shareholder meeting to urge them to share vaccine technology with the world.G…
Source: YouTubeCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 1All the Books of The Medical Futurist - 2 year(s) ago
We put together the most popular books from The Medical Futurist to provide a clear picture about the major trends shaping the future of medicine and healthcare. Digital health technologies, artificial intelligence, the future of 20 medical specialties, big pharma, data privacy, digital health investments and how technology giants such as Amazon or Google want to conquer healthcare in one…
Source: LeanpubCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 4The U.S. Insulin Crisis — Rationing a Lifesaving Medication Discovered in the 1920s | NEJM - 2 year(s) ago
Perspective from The New England Journal of Medicine — The U.S. Insulin Crisis — Rationing a Lifesaving Medication Discovered in the 1920s
Source: New England Journal of MedicineCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0McKinsey taught Big Pharma how to price-gouge - 2 year(s) ago
Leaked slides document the lies, sleaze and profiteering.
Source: MediumCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 27
KENILWORTH, N.J., Feb. 4, 2021 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today affirmed its position regarding use of ivermectin during the COVID-19 pandemic. Company scientists continue to carefully examine the findings of all available and emerging studies of ivermectin for the treatment of COVID-19 for evidence of efficacy […]
Source: Merck.comCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 30Killing Us Ohhhhhh So Slowly and Sweetly: A Parody Song SUGAR & GRAINs & Toxic OILs... Oh My!!!! - 3 year(s) ago
Addicting Us w/Sugar and Grains. Poisoning Us w/Industrial Seed Oils.Fructose in commercial sugar and processed fruits (commodities) is killing Americans met…
Source: YouTubeCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Unintended Consequences: Balancing innovation, profiteering within the Orphan Drug Act - 3 year(s) ago
The Orphan Drug Act, passed in good faith to help patients with rare diseases in 1983, has been at the center of multiple controversies in recent years. A study published last month in Health Affairs has added fuel to that fire.The key issue is that drugs granted orphan status may be given market exclusivity, allowing for lucrative monopolies and no competition. Some manufacturers have used this
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Evox has big pharma partners. Now it has $95M to bring its own drugs to the clinic - MedCity News - 3 year(s) ago
In the past year, Evox Therapeutics has inked alliances with two big pharma companies. The Series C financing now positions the biotech to advance to the clinic with its own exosome-based therapies.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
Where is #BigPharma on immune-related adverse events? "There is no question in my mind that industry has shied away from meaningfully supporting patient advocacy, or helping fill the gaps in medical research and education" More from @LCalabreseDO 👇 https://t.co/Vavr5lVxcq